Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
doi: 10.1007/s00125-011-2174-9
Overall I like this deal for Pfizer and I imagine they will continue to invest heavily in building out the clinical programs for Metseras portfolio beyond obesity, both to help stem revenue loss from LOEs of ELIQUIS and eventually leverage that commercial footprint towards its budding obesity portfolio.
et al: Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis. JAMA Neurology, April 7, 2025 Hullin Tang, PhD
Hers medical evaluation follows a similar model to other major telehealth platforms: an online health questionnaire reviewed by a licensed provider, with the possibility of a synchronous consultation if clinically indicated
US$ 29.79
US$ 20.82
US$ 24.75
US$ 26.09
US$ 26.85
US$ 25.17
